Tower Research Capital LLC (TRC) - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$300,842
-23.1%
2,060
+21.7%
0.01%
-30.8%
Q2 2023$391,083
+372360.0%
1,693
+291.0%
0.01%
+333.3%
Q1 2023$105
-88.8%
433
-86.6%
0.00%
-92.3%
Q4 2022$941
-99.8%
3,242
-44.1%
0.04%
+550.0%
Q3 2022$377,000
+113.0%
5,795
+133.4%
0.01%
+50.0%
Q2 2022$177,000
+73.5%
2,483
+138.5%
0.00%
+300.0%
Q1 2022$102,000
-41.0%
1,041
-49.0%
0.00%
-66.7%
Q4 2021$173,000
+71.3%
2,043
+61.6%
0.00%0.0%
Q3 2021$101,000
-54.9%
1,264
-45.1%
0.00%
-50.0%
Q2 2021$224,000
+339.2%
2,303
+425.8%
0.01%
+500.0%
Q1 2021$51,000
+1175.0%
438
+1023.1%
0.00%
Q4 2020$4,000
-92.2%
39
-91.0%
0.00%
-100.0%
Q3 2020$51,000
-75.6%
434
-76.5%
0.00%
-88.9%
Q2 2020$209,000
+226.6%
1,848
+92.9%
0.01%
+125.0%
Q1 2020$64,000
+326.7%
958
+477.1%
0.00%
+300.0%
Q4 2019$15,000
-63.4%
166
-65.4%
0.00%
-66.7%
Q3 2019$41,000
-6.8%
480
+201.9%
0.00%
+50.0%
Q2 2018$44,000
+2100.0%
159
+783.3%
0.00%
Q1 2018$2,000
-80.0%
18
-92.0%
0.00%
-100.0%
Q3 2017$10,000
+150.0%
225
-14.8%
0.00%
Q2 2017$4,000
-55.6%
264
-56.0%
0.00%
-100.0%
Q1 2017$9,000
+125.0%
600
+100.0%
0.00%
Q4 2016$4,0000.0%300
-12.0%
0.00%
Q3 2016$4,0003410.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$5,047,0003.31%
L1 Capital Pty Ltd 161,163$10,474,0002.05%
Avoro Capital Advisors LLC 1,535,000$99,760,0001.84%
Affinity Asset Advisors, LLC 100,000$6,499,0001.81%
GREAT POINT PARTNERS LLC 95,500$6,207,0001.50%
ARMISTICE CAPITAL, LLC 1,236,000$80,328,0001.39%
Affinity Asset Advisors, LLC 75,000$4,874,0001.36%
MPM BioImpact LLC 44,747$2,908,0000.69%
Baker Brothers Advisors 1,499,213$97,434,0000.64%
Perceptive Advisors 331,023$21,513,0000.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders